A double-blind, vehicle-controlled, multi-center phase III study of FMX-101 in patients with moderate to severe acne.

Trial Profile

A double-blind, vehicle-controlled, multi-center phase III study of FMX-101 in patients with moderate to severe acne.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Minocycline (Primary)
  • Indications Acne vulgaris
  • Focus Registrational; Therapeutic Use
  • Sponsors Foamix
  • Most Recent Events

    • 03 Aug 2017 According to a Foamix media release, first patient has been dosed in the study and top-line results are expected by mid-2018.
    • 03 Aug 2017 Status changed from planning to recruiting, according to a Foamix media release.
    • 04 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top